Search results for "Urinary system"

showing 10 items of 347 documents

Double-J stent insertion across vesicoureteral junction--is it a valuable initial approach in neonates and infants with severe primary nonrefluxing m…

2006

Abstract Objectives To evaluate the role of double- J stent insertion in perinatally detected primary nonrefluxing megaureters as a method to temporize treatment in patients with impaired renal function or to prevent function loss in patients treated expectantly, but deemed at high risk of deterioration. Methods Two neonates and 8 infants with a ureter greater than 10 mm and an obstructive excretion pattern, including 3 cases with renal function less than 40%, were selected to undergo double- J stent insertion for a 6-month period. Patients underwent surgery if the ureter redilated and the excretion pattern was obstructive at reassessment 3 months after stent removal. Results Stents were pl…

NephrologyMalemedicine.medical_specialtyMegaureterUrologyUrinary systemmedicine.medical_treatmentUrinary BladderRenal functionUreterInternal medicinemedicineHumansUreteral DiseasesVesico-Ureteral RefluxUrinary bladderbusiness.industryUrinary retentiondouble-J stent megaureter pediatricsInfant NewbornStentInfantUrinary Retentionmedicine.diseaseSurgerymedicine.anatomical_structureUrologic Surgical ProceduresFemaleStentsmedicine.symptomUreterbusinessUrology
researchProduct

Kelfiprim, a new sulpha-trimethoprim combination, versus cotrimoxazole, in the treatment of urinary tract infections: a multicentre, double-blind tri…

1982

A new combination of trimethoprim with a sulphonamide, named Kelfiprim, differs from cotrimoxazole in that: a) the sulpha drug is sulphamethopyrazine instead of sulphamethoxazole; b) the trimethoprim to sulpha ratio is 5:4 instead of 1:5;c) the presence of a long-acting sulphonamide allows the administration of a daily dose of one capsule, following an initial loading dose of two capsules; d) a reduced amount of trimethoprim is given, as compared to cotrimoxazole, without any decrease of efficacy. Kelfiprim [KP] was compared to contrimoxazole [Co] in a multicentre double blind trial. Sixty four patients suffering from acute and chronic infections of the upper and lower urinary tract entered…

NephrologyMalemedicine.medical_specialtySulfamethoxazoleUrologyUrinary systemUrineGastroenterologyLoading doseTrimethoprimDouble blindDouble-Blind MethodInternal medicineSulfanilamidesTrimethoprim Sulfamethoxazole Drug CombinationmedicineHumansClinical Trials as Topicbusiness.industrySulfaleneTrimethoprimSurgeryDrug CombinationsUrinary Tract InfectionsFemalebusinessmedicine.drugUrological research
researchProduct

Caki-1 cells as a model system for the interaction of renally secreted drugs with OCT3.

2008

<i>Background/Aims:</i> Organic cation transporters (OCT) in the proximal tubules (PTs) participate in the renal secretion of several therapeutic agents. The exact role of OCT3 in renal secretion remains undetermined, partially due to the lack of an appropriate in vitro model system. The current work introduces the PT representative cell line, Caki-1, as a model system for studying the involvement of OCT3 in renal secretion. <i>Methods:</i> Caki-1 cells were characterized for OCT3 expression via real-time RT-PCR and immunocytochemical staining techniques. Uptake kinetics of OCT3 in Caki-1 cells was determined using prototypical substrates and inhibitors. Inhibition o…

Nephrologymedicine.medical_specialty1-Methyl-4-phenylpyridiniumOrganic Cation Transport ProteinsPhysiologyCell SurvivalUrinary systemmacromolecular substancesPharmacologyurologic and male genital diseasesCell LineXenobioticsKidney Tubules ProximalPhysiology (medical)Internal medicinemedicineHumansSecretionRNA MessengerKidneyOrganic cation transport proteinsbiologyDose-Response Relationship Drugbusiness.industryOrganic Cation Transporter 1Organic Cation Transporter 2Epithelial CellsGeneral MedicineDrug interactionmedicine.diseaseImmunohistochemistryQuaternary Ammonium CompoundsKineticsEndocrinologymedicine.anatomical_structureNephrologyRenal physiologybiology.proteinbusinessKidney diseaseNephron. Physiology
researchProduct

Iron replacement therapy in the management of anaemia in non-dialysis Chronic kidney disease patients: Perspective of the Spanish Nephrology Society …

2021

This work presents an update on the management of iron deficiency in patients with chronic kidney disease (CKD), either with or without anaemia. A review is made of the recommendations of the guidelines for the treatment of iron deficiency in CKD. It also presents new studies on iron deficiency in patients with CKD, as well as new findings about iron therapy and its impact on clinical outcomes.Anaemia is a common complication of CRF, and is associated with a decrease in the quality of life of the patients, as well as an increase in morbidity and mortality. Iron deficiency (absolute or functional) is common in non-dialysis chronic kidney disease patients, and may cause anaemia or a low respo…

Nephrologymedicine.medical_specialtyPediatricsAnemiaPopulation030232 urology & nephrology030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicinemedicineeducationEnfermedad renal crónicaDéficit férricoeducation.field_of_studyHemoglobinabusiness.industryAnemiaFerropeniaIron deficiencymedicine.diseaseDiseases of the genitourinary system. UrologyNephrologyHeart failureRC870-923businessComplicationHierroKidney diseaseNefrologia
researchProduct

Unilateral multicystic dysplastic kidney in infants exposed to antiepileptic drugs during pregnancy

2007

Prenatal exposure to antiepileptic drugs (AEDs) increases the risk of major congenital malformations (MCM) in the fetus. AED-related abnormalities include heart and neural tube defects, cleft palate, and urogenital abnormalities. Among the various congenital anomalies of the kidney and urinary tract (CAKUT), multicystic dysplastic kidney (MCDK) disease is one of the most severe expressions. Although prenatal ultrasound (US) examination has increased the prenatal diagnosis of MCDK, the pathogenesis is still unclear. We report on four cases of MCDK in infants of epileptic women treated with AEDs during pregnancy. From October 2003 to June 2006, we observed four infants with unilateral MCDK bo…

Nephrologymedicine.medical_specialtyTime FactorsVoiding cystourethrogramUrinary systemMulticystic dysplastic kidneyPrenatal diagnosisUltrasonography PrenatalPregnancyInternal medicineProhibitinsmedicineHumansMulticystic Dysplastic KidneyMaternal-Fetal ExchangeFetusPregnancyEpilepsymedicine.diagnostic_testbusiness.industryObstetricsInfant Newbornmedicine.diseaseSurgeryMulticystic dysplastic kidney . Antiepileptic drugs . Major congenital anomalies . InfantCarbamazepineTreatment OutcomeNephrologyPhenobarbitalPrenatal Exposure Delayed EffectsPediatrics Perinatology and Child HealthGestationAnticonvulsantsFemalebusinessFollow-Up Studies
researchProduct

Correlation between clinical response and urinary interleukin levels using different doses and intravesical administration schedules of interferon-al…

1993

A total of 62 patients at high risk for recurrence of superficial bladder cancer were selected for a study designed to compare the prophylactic efficacy of different doses and schedules of sequential intravesical instillations of epirubicin and interferon-alpha-2b and to evaluate which sequence could enhance the release of cytokines in the urine. Our investigations showed a significant increase in urinary concentrations of interleukins in patients who received the sequential intravesical administration of epirubicin and interferon-alpha-2b. Higher urinary concentrations of interleukins and a lower recurrence rate were detected in patients who received interferon-alpha-2b 24 h after epirubic…

Nephrologymedicine.medical_specialtyUrologyUrinary systemUrologyAlpha interferonIntravesical immunotherapyUrineInterferon alpha-2PharmacologyDrug Administration ScheduleIntravesical chemotherapyInterferon-alpha-2bSettore MED/24 - UrologiaInternal medicinemedicineHumansCombined Modality TherapyEpirubicinbusiness.industryInterleukinsInterferon-alphaInterleukinCombined Modality TherapyRecombinant ProteinsClinical trialInterleukins (urinary concentration of)Administration IntravesicalUrinary Bladder NeoplasmsInterleukin-2Interleukin-4Neoplasm Recurrence LocalbusinessInterleukin-1Epirubicinmedicine.drugUrological Research
researchProduct

Topical estrogens and non-hormonal preparations for postmenopausal vulvovaginal atrophy: An EMAS clinical guide

2021

Introduction: Vulvovaginal atrophy (VVA) is a chronic condition caused by estrogen deficiency. It affects around 50% of postmenopausal women, reducing their general and sexual quality of life as well as the quality of their personal relationships. Aim: The aim of this clinical guide is to set out an individualized approach to the management of VVA with topical estrogens and non-hormonal preparations. Materials and methods: Literature review and consensus of expert opinion. Summary recommendations: An individualized approach is required for the management of VVA. Topical low-dose estrogens are effective and also alleviate urinary incontinence and prevent recurrent urinary tract infections. W…

Non-Hormonal Preparationsmedicine.medical_specialtyChronic conditionmedicine.drug_classmedicine.medical_treatmentUrinary systemVaginal DiseasesUrinary incontinenceVulvovaginal atrophyGeneral Biochemistry Genetics and Molecular BiologyVulvovaginal Atrophy03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicinemedicineHumansEndocrine system030212 general & internal medicineExpert Testimony030219 obstetrics & reproductive medicinebusiness.industryObstetrics and GynecologyEstrogensPostmenopauseTopical EstrogensAdministration IntravaginalEstrogenPractice Guidelines as TopicQuality of LifeFemaleVulvar DiseasesAtrophymedicine.symptombusinessAdjuvantMaturitas
researchProduct

Radioimmunoassay of Plasma and Urinary Norepinephrine

1989

Various analytical methods, such as fluorimetry, radioenzymic assay and in particular liquid chromatography are used for the analysis of norepinephrine (NA) in body fluids and tissue homogenates. These procedures, however, often lack sensitivity, are expensive and/or time consuming. Basing on our previous reports on the radioimmunoassay of chemically modified serotonin1, 5-hydroxy-3-indole acetic acid2 and normetanephrine (NMN)3, a sensitive radioimmunoassay of the N-acetyl,3-methoxy analogue of urinary and plasma norepinephrine was developed.

Norepinephrine (medication)chemistry.chemical_compoundChromatographyPlasma norepinephrineChemistryUrinary systemmedicineRadioimmunoassayNormetanephrinemedicine.drug
researchProduct

Mild dehydration: a risk factor of urinary tract infection?

2003

Bacterial growth in the urinary tract is usually prevented by host factors including bacterial eradication by urinary and mucus flow, urothelial bactericidal activity, urinary secretory IgA, and blood group antigens in secretions which interfere with bacterial adherence. Bacterial eradication from the urinary tract is partially dependent on urine flow and voiding frequency. Therefore, it seems logical to postulate a connection between fluid intake and the risk of urinary tract infections (UTIs). However, experimental and clinical data on this subject are conflicting. Experimental studies concerning the effect of water intake on susceptibility and course of UTIs were predominantly performed …

Nutrition and DieteticsDehydrationUrinary systemDrinkingMedicine (miscellaneous)PhysiologyHost defenceHydrogen-Ion ConcentrationUrineBiologyurologic and male genital diseasesAntimicrobialMucusfemale genital diseases and pregnancy complicationsAnti-Bacterial AgentsBlood group antigensFluid intakeRisk FactorsMild dehydrationUrinary Tract InfectionsImmunologyHumansSecretory IgAEuropean Journal of Clinical Nutrition
researchProduct

Cancer Stem Cell Biomarkers Predictive of Radiotherapy Response in Rectal Cancer: A Systematic Review

2021

Background: Rectal cancer (RC) is one of the most commonly diagnosed and particularly challenging tumours to treat due to its location in the pelvis and close proximity to critical genitourinary organs. Radiotherapy (RT) is recognised as a key component of therapeutic strategy to treat RC, promoting the downsizing and downstaging of large RCs in neoadjuvant settings, although its therapeutic effect is limited due to radioresistance. Evidence from experimental and clinical studies indicates that the likelihood of achieving local tumour control by RT depends on the complete eradication of cancer stem cells (CSC), a minority subset of tumour cells with stemness properties. Methods: A systemati…

OncologyNeo-adjuvant radiotherapymedicine.medical_specialtyColorectal cancermedicine.medical_treatmentReviewQH426-470RadiosensitivityCancer stem cellRadioresistanceInternal medicineBiomarkers TumorGeneticsmedicineHumansGenetics (clinical)Rectal cancer (RC)biologyRectal NeoplasmsCancer stem cellsGenitourinary systembusiness.industryCD44Therapeutic effectmedicine.diseaseOrganoidsRadiation therapyTreatment OutcomeSystematic reviewIn vitro radiotherapyNeoplastic Stem Cellsbiology.proteinbusinessGenes
researchProduct